BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 16287878)

  • 1. Experimental models of human bladder carcinogenesis.
    Crallan RA; Georgopoulos NT; Southgate J
    Carcinogenesis; 2006 Mar; 27(3):374-81. PubMed ID: 16287878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental bladder carcinogenesis-rodent models.
    Oliveira PA; Colaco A; De la Cruz P LF; Lopes C
    Exp Oncol; 2006 Mar; 28(1):2-11. PubMed ID: 16614700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immortalized human urothelial cells as a model of arsenic-induced bladder cancer.
    Eblin KE; Bredfeldt TG; Gandolfi AJ
    Toxicology; 2008 Jun; 248(2-3):67-76. PubMed ID: 18456381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological pathways to bladder carcinogenesis.
    Gonzalgo ML; Schoenberg MP; Rodriguez R
    Semin Urol Oncol; 2000 Nov; 18(4):256-63. PubMed ID: 11101088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental models of bladder cancer: a critical review.
    Raghavan D; Debruyne F; Herr H; Jocham D; Kakizoe T; Okajima E; Sandberg A; Tannock I
    Prog Clin Biol Res; 1986; 221():171-208. PubMed ID: 3543942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular changes in development and progression of urothelial carcinoma].
    Hartmann A
    Verh Dtsch Ges Pathol; 2003; 87():172-84. PubMed ID: 16888910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular mechanisms of chemically induced carcinogenesis].
    Palut D; Kostka G; Adamczyk M
    Rocz Panstw Zakl Hig; 1998; 49(1):35-54. PubMed ID: 9734231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Procarcinogen Activation and Mutational Signatures Model the Initiation of Carcinogenesis in Human Urothelial Tissues In Vitro.
    Baker SC; Mason AS; Southgate J
    Eur Urol; 2020 Aug; 78(2):143-147. PubMed ID: 32349929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms in urinary bladder carcinogenesis.
    Volanis D; Papadopoulos G; Doumas K; Gkialas I; Delakas D
    J BUON; 2011; 16(4):589-601. PubMed ID: 22331708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mouse orthotopic models for bladder cancer research.
    Chan E; Patel A; Heston W; Larchian W
    BJU Int; 2009 Nov; 104(9):1286-91. PubMed ID: 19388981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro studies on the pathogenesis of bladder cancer.
    Masters JR; Petzoldt JL
    Verh Dtsch Ges Pathol; 1993; 77():157-60. PubMed ID: 7511275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canine invasive transitional cell carcinoma cell lines: in vitro tools to complement a relevant animal model of invasive urinary bladder cancer.
    Dhawan D; Ramos-Vara JA; Stewart JC; Zheng R; Knapp DW
    Urol Oncol; 2009; 27(3):284-92. PubMed ID: 18562222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organotypic and 3D reconstructed cultures of the human bladder and urinary tract.
    Varley CL; Southgate J
    Methods Mol Biol; 2011; 695():197-211. PubMed ID: 21042974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of annexin a1 induced by terephthalic acid calculi in rat bladder cancer.
    Cui L; Wang Y; Shi Y; Zhang Z; Xia Y; Sun H; Wang S; Chen J; Zhang W; Lu Q; Song L; Wei Q; Zhang R; Wang X
    Proteomics; 2007 Nov; 7(22):4192-202. PubMed ID: 17994624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclooxygenase-2 expression on urothelial and inflammatory cells of cystoscopic biopsies and urine cytology as a possible predictive marker for bladder carcinoma.
    Moussa M; Omran Z; Nosseir M; Lotfy A; Swellam T
    APMIS; 2009 Jan; 117(1):45-52. PubMed ID: 19161536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hybrid discrete-continuous model of invasive bladder cancer.
    Kashdan E; Bunimovich-Mendrazitsky S
    Math Biosci Eng; 2013 Jun; 10(3):729-42. PubMed ID: 23906146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detection of oncoprotein E7 HPV16 in the cancer and normal urinary bladder urothelium].
    Volgareva GM; Zavalishina LE; Golovina DA; Andreeva IuIu; Ermilova VD; Cheban NL; Kuevda DA; Trofimova OB; Shipulina OIu; Pavlova LS; Petrov AN; Matveev VB; Shtil' AA; Frank GA
    Arkh Patol; 2009; 71(1):29-30. PubMed ID: 19514355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogenic properties of the mutated forms of fibroblast growth factor receptor 3b.
    Bernard-Pierrot I; Brams A; Dunois-Lardé C; Caillault A; Diez de Medina SG; Cappellen D; Graff G; Thiery JP; Chopin D; Ricol D; Radvanyi F
    Carcinogenesis; 2006 Apr; 27(4):740-7. PubMed ID: 16338952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EDTA-induced urothelial cell shedding for the treatment of superficial bladder cancer in the mouse.
    Nativ O; Dalal E; Hidas G; Aronson M
    Int J Urol; 2006 Oct; 13(10):1344-6. PubMed ID: 17010016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The natural history of carcinogenesis: implications of experimental carcinogenesis in the genesis of human cancer.
    Pitot HC; Goldsworthy T; Moran S
    J Supramol Struct Cell Biochem; 1981; 17(2):133-46. PubMed ID: 7033553
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.